Sunday, November 9, 2025
HomeIndustriesHealthcare

Healthcare

Publication of RGN-259 Phase 3 Clinical Trial Results in Patients with Neurotrophic Keratopathy

RegeneRx Biopharmaceuticals, Inc., a clinical-stage drug development company focused on tissue protection, repair, and regeneration, is reporting a new scientific publication describing the safety...

Burning Rock Received FDA Breakthrough Device Designation for its OverC Multi-Cancer Detection

Burning Rock, a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, announced that its OverC™...

Force Therapeutics Now Available in AWS Marketplace

Force Therapeutics, a leading full-suite digital care management platform, announced its availability in AWS Marketplace, a curated digital catalog that makes it easy for...

CardieX Subsidiary ATCOR Partners with Invaryant to Enable Clinical Trials

CardieX Limited, a global health technology company focused on patient-centric healthcare research and improving clinical trial patient outcomes, announced a partnership between its ATCOR...

Sesen Bio and Carisma Therapeutics Announce Substantial Increase to Expected Special Cash Dividend

Sesen Bio, Inc. and Carisma Therapeutics Inc., a privately-held, clinical stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, announced an amendment to...
0FansLike
0FollowersFollow
spot_img

Hot Topics